rs141885504

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_002137.4(HNRNPA2B1):​c.744C>T​(p.Pro248Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000351 in 1,611,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00035 ( 0 hom. )

Consequence

HNRNPA2B1
NM_002137.4 synonymous

Scores

1
11

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.06

Publications

0 publications found
Variant links:
Genes affected
HNRNPA2B1 (HGNC:5033): (heterogeneous nuclear ribonucleoprotein A2/B1) This gene belongs to the A/B subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has two repeats of quasi-RRM domains that bind to RNAs. This gene has been described to generate two alternatively spliced transcript variants which encode different isoforms. [provided by RefSeq, Jul 2008]
HNRNPA2B1 Gene-Disease associations (from GenCC):
  • inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • oculopharyngeal muscular dystrophy 2
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Genomics England PanelApp, ClinGen
  • inclusion body myopathy with Paget disease of bone and frontotemporal dementia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.058010817).
BP6
Variant 7-26193672-G-A is Benign according to our data. Variant chr7-26193672-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 474503.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.06 with no splicing effect.
BS2
High AC in GnomAd4 at 47 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNRNPA2B1NM_002137.4 linkc.744C>T p.Pro248Pro synonymous_variant Exon 8 of 11 ENST00000618183.5 NP_002128.1 P22626-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNRNPA2B1ENST00000618183.5 linkc.744C>T p.Pro248Pro synonymous_variant Exon 8 of 11 5 NM_002137.4 ENSP00000478691.2 P22626-2A0A087WUI2

Frequencies

GnomAD3 genomes
AF:
0.000309
AC:
47
AN:
151944
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000284
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000471
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000358
AC:
89
AN:
248678
AF XY:
0.000372
show subpopulations
Gnomad AFR exome
AF:
0.000248
Gnomad AMR exome
AF:
0.0000594
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000166
Gnomad FIN exome
AF:
0.000555
Gnomad NFE exome
AF:
0.000593
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000355
AC:
518
AN:
1459282
Hom.:
0
Cov.:
30
AF XY:
0.000339
AC XY:
246
AN XY:
726032
show subpopulations
African (AFR)
AF:
0.000210
AC:
7
AN:
33316
American (AMR)
AF:
0.000113
AC:
5
AN:
44128
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26080
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39550
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85898
European-Finnish (FIN)
AF:
0.000506
AC:
27
AN:
53390
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
0.000406
AC:
451
AN:
1110868
Other (OTH)
AF:
0.000332
AC:
20
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000309
AC:
47
AN:
151944
Hom.:
0
Cov.:
32
AF XY:
0.000283
AC XY:
21
AN XY:
74186
show subpopulations
African (AFR)
AF:
0.000242
AC:
10
AN:
41344
American (AMR)
AF:
0.0000655
AC:
1
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.000284
AC:
3
AN:
10550
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000471
AC:
32
AN:
68002
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000445
Hom.:
0
Bravo
AF:
0.000351
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000371
AC:
45
EpiCase
AF:
0.000437
EpiControl
AF:
0.000298

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 Benign:1
Jan 18, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
15
DANN
Benign
0.32
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.49
T
MetaRNN
Benign
0.058
T
MetaSVM
Benign
-1.0
T
PhyloP100
2.1
Sift4G
Uncertain
0.039
D
Vest4
0.21
MVP
0.64
ClinPred
0.086
T
GERP RS
3.7
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141885504; hg19: chr7-26233292; API